Acute effects of breaking up sitting time with isometric exercise on cardiovascular health: Randomized crossover trial.
Gustavo Oliveira da SilvaJuliana Ferreira de CarvalhoHélcio KanegusukuBreno Quintella FarahMarilia de Almeida CorreiaRaphael Mendes Ritti-DiasPublished in: Scandinavian journal of medicine & science in sports (2021)
The objective of this study was to analyze the acute effects of breaking up prolonged sitting with isometric exercise on the cardiovascular health of sedentary adults. This is a three-condition randomized crossover trial. The sample was comprised of 17 subjects (11 women; 29 ± 10 years old; 25,1 ± 5,1 kg/m2 ). The participants completed, in randomized order, three experimental conditions (control, breaks with isometric leg extension exercise, and breaks with walking), with the order of the conditions determined through simple automatic randomization. All the conditions had in common a sitting period of 3 h. During the conditions with isometric exercise and walking breaks the participants performed breaks with isometric leg extension exercise and with walking every 30 min, while in the control condition they remained seated with no breaks. Before and after this period, vascular function (primary outcome), blood pressure, and cardiac autonomic modulation (secondary outcomes) were measured. Generalized estimated equations were used to analyze the data. The results did not indicate significant interaction effects for vascular function among experimental conditions (p > 0,05 for all). We also did not find significant interaction effects for systolic or diastolic blood pressure among the conditions (p > 0,05 for all). The heart rate variability parameters did not present significant interaction effects among conditions (p > 0,05 for all). In conclusion, breaking up sitting with isometric exercise does not seem to lead to significant effects on the cardiovascular health of sedentary adults.
Keyphrases
- resistance training
- blood pressure
- high intensity
- physical activity
- heart rate variability
- phase iii
- double blind
- open label
- heart rate
- body composition
- placebo controlled
- phase ii
- left ventricular
- clinical trial
- liver failure
- heart failure
- randomized controlled trial
- drug induced
- metabolic syndrome
- machine learning
- hepatitis b virus
- aortic dissection
- big data
- insulin resistance
- polycystic ovary syndrome
- extracorporeal membrane oxygenation
- ejection fraction
- glycemic control